Cargando…
Pretreatment rate of decay in forced vital capacity predicts long-term response to pirfenidone in patients with idiopathic pulmonary fibrosis
Pirfenidone reduces functional decline in patients with Idiopathic Pulmonary Fibrosis (IPF). However, response to treatment is highly heterogeneous. We sought to evaluate whether response to pirfenidone is influenced by the pretreatment rate of forced vital capacity (FVC) decline. Fifty-six IPF pati...
Autores principales: | Biondini, Davide, Balestro, Elisabetta, Lacedonia, Donato, Cerri, Stefania, Milaneschi, Rosanna, Luppi, Fabrizio, Cocconcelli, Elisabetta, Bazzan, Erica, Clini, Enrico, Foschino Barbaro, Maria Pia, Gregori, Dario, Cosio, Manuel G, Saetta, Marina, Spagnolo, Paolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5899162/ https://www.ncbi.nlm.nih.gov/pubmed/29654244 http://dx.doi.org/10.1038/s41598-018-24303-4 |
Ejemplares similares
-
High-Resolution Computed Tomography (HRCT) Reflects Disease Progression in Patients with Idiopathic Pulmonary Fibrosis (IPF): Relationship with Lung Pathology
por: Cocconcelli, Elisabetta, et al.
Publicado: (2019) -
High-Resolution CT Change over Time in Patients with Idiopathic Pulmonary Fibrosis on Antifibrotic Treatment
por: Balestro, Elisabetta, et al.
Publicado: (2019) -
Heart Failure is Highly Prevalent and Difficult to Diagnose in Severe Exacerbations of COPD Presenting to the Emergency Department
por: Tinè, Mariaenrica, et al.
Publicado: (2020) -
Prognostic role of MUC5B rs35705950 genotype in patients with idiopathic pulmonary fibrosis (IPF) on antifibrotic treatment
por: Biondini, Davide, et al.
Publicado: (2021) -
Critical Review of the Evolution of Extracellular Vesicles’ Knowledge: From 1946 to Today
por: Bazzan, Erica, et al.
Publicado: (2021)